Get the Stockscreener App
1.52
1.94%
-0.03
After Hours:
1.50
-0.02
-1.32%
Calidi Biotherapeutics Inc stock is traded at $1.52, with a volume of 107.53K.
It is down -1.94% in the last 24 hours and down -3.18% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.55
Open:
$1.54
24h Volume:
107.53K
Relative Volume:
0.22
Market Cap:
$8.29M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-2.063
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-3.18%
6M Performance:
-73.70%
1Y Performance:
-89.27%
1-Day Range:
$1.515
$1.57
1-Week Range:
$1.4101
$1.59
52-Week Range:
$1.41
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.52 | 8.29M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.39 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.48 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.91 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
836.39 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.29 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
How Calidi Biotherapeutics Inc. stock reacts to stronger dollarWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Using RSI to spot recovery in Calidi Biotherapeutics Inc.July 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsBear Alert & Momentum Based Trading Ideas - newser.com
What momentum shifts mean for Calidi Biotherapeutics Inc.Portfolio Return Report & Real-Time Stock Movement Alerts - newser.com
Calidi Biotherapeutics Inc.’s volatility index tracking explained2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Will Calidi Biotherapeutics Inc. stock see insider buying2025 Top Gainers & Community Verified Trade Signals - newser.com
Can Calidi Biotherapeutics Inc. stock beat market expectations this quarterEarnings Overview Report & Reliable Intraday Trade Plans - newser.com
Key resistance and support levels for Calidi Biotherapeutics Inc.Breakout Watch & Daily Chart Pattern Signal Reports - newser.com
Can Calidi Biotherapeutics Inc. stock rebound after recent weaknessQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
How to manage a losing position in Calidi Biotherapeutics Inc.July 2025 Catalysts & Smart Allocation Stock Reports - newser.com
Full technical analysis of Calidi Biotherapeutics Inc. stock2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Using data models to predict Calidi Biotherapeutics Inc. stock movement2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.34%
Cap:
|
Volume (24h):